Loading…

Tissue-Specific Myeloablative Conditioning with Total Marrow Irradiation Enhances Gut Microbiome Diversity and Mitigates Gvhd: A Novel Therapeutic Approach

Background: Traditional systemic myeloablative conditioning methods, such as total body irradiation (TBI) and chemotherapy, severely damage the gastrointestinal (GI) tract and induce graft-versus-host disease (GVHD), negatively impacting patient outcomes in allogeneic transplantation. This gut damag...

Full description

Saved in:
Bibliographic Details
Published in:Blood 2024-11, Vol.144 (Supplement 1), p.3393-3393
Main Authors: Lim, Ji Eun, Sargur Madabushi, Srideshikan, Lemecha Shukare, Mengistu, Ghimire, Hemendra, Paredes, Jenny, Mokhtari, Sally, Sanchez, James F., Sandhu, Karamjeet S, Salhotra, Amandeep, Nakamura, Ryotaro, Wong, Jeffrey, Stein, Anthony S., Schaue, Dorothy, van den Brink, Marcel R.M., Al Malki, MHD Monzr M., Storme, Guy, Hui, Susanta
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Traditional systemic myeloablative conditioning methods, such as total body irradiation (TBI) and chemotherapy, severely damage the gastrointestinal (GI) tract and induce graft-versus-host disease (GVHD), negatively impacting patient outcomes in allogeneic transplantation. This gut damage disrupts the microbiota, leading to dysbiosis. Despite numerous efforts, post-treatment interventions have achieved limited success so far. We developed a high-precision total marrow irradiation (TMI) in vivo model, enabling tissue specific dose delivery with higher dose of radiation being delivered to disease sites while sparing other at-risk organs. We previously showed that reducing radiation dose to the gut reduces MadCam1 expression on gut endothelial cells, consequently reducing α4β7 integrin-mediated T cell adhesion to the gut, which may result in less GVHD. Here, we investigated the impact of TMI radiation delivery on gut biodiversity and overall biological responses. Methods: Balb/c (H2d) mice were subjected to either 8 Gy (4Gy/fraction in 2 fractions in 6 hrs) of TBI or TMI with the latter limiting GI exposure to 4 Gy (n≥4, duplicate study). Twenty-four hours post-irradiation, the mice received T cell-depleted B6 (H2b) donor bone marrow cells and enriched spleen conventional T cells. We collected fecal samples pre-irradiation, then on days 7 and 14 post-bone marrow transplant (BMT) for microbiome analysis using shotgun metagenomics (Transnetyx) and analyzed on the One Codex platform. We assessed radiation-induced effects on GI using immunofluorescence and electron microscopy and evaluated GI structure-function by analyzing microvilli structure, gut permeability (FITC Dextran), and inflammatory cytokines analysis. Results: The average microvilli height is significantly (p=0.003) reduced in the TBI group (485.93 ± 24 nm) compared to the TMI group (631.69 ± 32.29 nm), suggesting TMI preserves GI structures better than TBI. In addition, FITC-dextran uptake in serum showed increased leakiness in TBI treated mice than TMI mice (Mean Fluorescence; 7.8X 105 vs 6.01X 105, p=0.0233) suggesting less damage to GI in TMI treatment. Fecal microbiome analysis showed radiation conditioning alters alpha diversity (species diversity) as indicated by a lower Shannon Diversity Index (SDI median: 1.2 vs ~1.0) at post-BMT time-points. However, higher gut microbiome diversity was detected in TMI than TBI-treated mice at Day 7 post-BMT (Median SDI 0.9 vs 1.1). Moreover, TMI
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2024-210774